Combination of cis-4-hydroxy-L-proline and N-methyl-cis-4-hydroxy- L- proline for use as a therapeutic agent, in particular in cancer treatment

摘要

The disclosure relates to a combination of cis-4-hydroxy-L- proline and n-methyl-cis-4-hydroxy-L-proline for use as a therapeutic agent, in particular in cancer treatment. Also disclosed is the use of the individual substances for treating hormone-sensitive prostate cancer.